Company release, November 18, 2004
New Delhi
Glaxo Smith Kline, Sri Lanka has appointed Arms Healthcare, a Division of the Rs 40 Crore Arms Communications to work on its biggest selling brand PANADOL.
Arms will create the entire medical communications package for Panadol Activfast and Panadol 15mg/kg pedeactric program,aimed at the medical community.
GSKs decision on the appointment of Arms in addition to O&M Sri Lanka was influenced by the recommendation from GSK DElhi for whom Arms has launched the Crocin 15mg/kg program and soon the Crocin Quik.
Arms Healthcare the first Local agency to service medical communications overseas. Other cliients of Arms Healthcare are Ranbaxy, Elli Lily and Dabur
For more information please contact:
Bharat Bharadwaj,
vice-president,
Arms Healthcare
bharat@jointarms.com